Suchergebnisse - "Imam, Faisal"

PubPharm (91)

21

Effect of Roflumilast in airways disorders via dual inhibition of phosphodiesterase and Ca2+-channel

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2020

von Imam, F. | Rehman, N. | Ansari, M. | +3

22

Protective Effect of RIVA Against Sunitinib-Induced Cardiotoxicity by Inhibiting Oxidative Stress-Mediated Inflammation : Probable Role of TGF-β and Smad Signaling

enthalten in: Cardiovascular toxicology | 2020

von Imam, F. | Al-Harbi, N. | Khan, M. | +6

23

Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats

enthalten in: Journal of thrombosis and thrombolysis | 2020

von Al-Harbi, N. | Imam, F. | Alharbi, M. | +9

24

Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats

enthalten in: Journal of thrombosis and thrombolysis | 2020

von Al-Harbi, N. | Imam, F. | Alharbi, M. | +9

25

Role of rivaroxaban in sunitinib-induced renal injuries via inhibition of oxidative stress-induced apoptosis and inflammation through the tissue nacrosis factor-α induced nuclear factor-κappa B signaling pathway in rats

enthalten in: Journal of thrombosis and thrombolysis | 2020

von Al-Harbi, N. | Imam, F. | Alharbi, M. | +9

26

Role of carnitine in regulation of hypoglycemia-induced hypertension and cardiac hypertrophy

enthalten in: ResearchSquare.com | 2020

von Alanazi, W. | Al-Harbi, N. | Imam, F. | +6

27

Evaluation of bronchodialatory and antimicrobial activities of Otostegia fruticosa : A multi-mechanistic approach

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2020

von Ansari, M. | Rehman, N. | Karim, A. | +4

28

Development of Lipomer Nanoparticles for the Enhancement of Drug Release, Anti-microbial Activity and Bioavailability of Delafloxacin

enthalten in: Pharmaceutics | 2020

von Anwer, M. | Iqbal, M. | Muharram, M. | +5

29

Adverse drug reaction prevalence and mechanisms of action of first-line anti-tubercular drugs

enthalten in: Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society | 2020

von Imam, F. | Sharma, M. | Khayyam, K. | +5

30

Corrigendum to "Apremilast prevent doxorubicin-induced apoptosis and inflammation in heart through inhibition of oxidative stress mediated activation of NF-κB signaling pathways" [Pharmacol. Rep. 70 (2018) 993-1000

enthalten in: Pharmacological reports : PR | 2019

von Imam, F. | Al-Harbi, N. | Al-Harbi, M. | +10

ErratumFor: Pharmacol Rep. 2018 Oct;70(5):993-1000. - PMID 30118964